$4.98
-0.4%$4.98
-0.4%Vota per vedere il sentimento generale su Injective adesso
*Il profitto previsto è calcolato in base al prezzo medio dei token di quest'anno. Tieni presente che questa non è una consulenza finanziaria.

Data la volatilità del mercato delle criptovalute, tutti sono curiosi di conoscere la direzione e il prezzo di Injective, sia a breve che a lungo termine.
Injective può arrivare fino a $8.3 da qui al 2030.
Il ROI potenziale dell'acquisto di Injective al prezzo attuale di $4.98 è +66.00% , il massimo storico di Injective è $52.62 .
Injective si è mosso -0.4% nelle ultime 24 ore e +6.64% negli ultimi 7 giorni. Per ulteriori informazioni, vedere Injective prezzo ora.
For 2026, Injective is estimated to achieve an average price of $4.96, with an expected of high $6.9 and a potential low of $2.88. Buying Injective at the current price of $4.98 can potentially yield 0 in 2026.
Past trends and patterns indicate that Injective may make a high of $8.3, with the lowest price of $4.27 in 2027. So buying Injective at the current price of $4.98, the potential ROI based on average price of $5.93 in 2027 will be +19.00%.
Injective is forecasted to hover around $7.12 for most parts in 2028, with an expected low of $5.12 and expected high of $8.4. Based on this forecast, you can expect a potential ROI of $4.98 if you buy at current market price of +42.00%.
Based on historical data, Injective may make a high of $8.85, with $6.05 as the lowest price in 2029. So if you were to buy Injective at the current price of $4.98, the potential ROI for you in 2029 is $7.76 as it makes its way to the average price of +55.00%.
In 2030, the lowest price to be seen from Injective is estimated at $4.23, while the peak price of the year may well be around $9.96. With an average price of $8.3, your potential ROI in 2030 if you buy at market price of $4.98 is +66.00%.
Following the market sentiment in previous years, Injective is predicted to make movements between $8.04 and $12.42, with the average price of $9.13 in 2031. Buying Injective at current price of $4.98 should bring you the potential ROI of +83.00% if you HODL it until 2031.
| Anno | Prezzo minimo | Prezzo più alto | Average price | Variazione |
|---|---|---|---|---|
| 2026 | $2.88 | $6.9 | $4.96 | -- |
| 2027 | $4.27 | $8.3 | $5.93 | +19.00% |
| 2028 | $5.12 | $8.4 | $7.12 | +42.00% |
| 2029 | $6.05 | $8.85 | $7.76 | +55.00% |
| 2030 | $4.23 | $9.96 | $8.3 | +66.00% |
| 2031 | $8.04 | $12.42 | $9.13 | +83.00% |
Injective | 0.2017 INJ |
|---|---|
$1USD | |
€0.8733EUR | |
₹95.42INR | |
Rp18,009.72IDR | |
$1.41CAD | |
£0.7483GBP | |
฿33.29THB |
Injective | 0.2017 INJ |
|---|---|
₽77.3RUB | |
R$5.16BRL | |
د.إ3.67AED | |
₺46.8TRY | |
¥6.79CNY | |
¥162.06JPY | |
$7.84HKD |

INJ announces a 50,000 token buyback plan, integrating stablecoin payments, RWA assets, and AI features following its mainnet upgrade. Analyzing the strategic logic behind this three-in-one narrative and the competitive landscape among public blockchains.

BlackRock ranks first in the cash flow of Bitcoin spot ETFs, and MicroStrategy is buying more Bitcoin. JPMorgan Chase believes that the probability of approval for the May spot Ethereum ETF does not exceed 50%.
Injective(INJ) ha una previsione di prezzo futura di $9.13. Si prevede che entro 2027, Injective(INJ) possa raggiungere un nuovo massimo di $52.62. Considerando la sua capitalizzazione di mercato di 88, si prevede che Injective(INJ) continuerà il suo forte slancio di crescita.